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Gangliosides (sialic acid-containing glycosphingolipids) help
regulate many important biological processes, including cell
proliferation, signal transduction, and differentiation, via for-
mation of functional microdomains in plasma membranes. The
structural diversity of gangliosides arises from both the cer-
amide moiety and glycan portion. Recently, differing molecular
species of a given ganglioside are suggested to have distinct bio-
logical properties and regulate specific and distinct biological
events. Elucidation of the function of each molecular species is
important and will provide new insights into ganglioside biol-
ogy. Gangliosides are also suggested to be involved in skeletal
muscle differentiation; however, the differential roles of gangli-
osidemolecular species remain unclear. Here we describe strik-
ing changes in quantity and quality of gangliosides (particularly
GM3)duringdifferentiationofmouseC2C12myoblast cells and
key roles played by distinct GM3molecular species at each step
of the process.
Glycosphingolipids (GSLs)3 are constituents of eukaryotic
cell membranes located exclusively on the outer leaflet of the
plasma membrane. Gangliosides, a subgroup of GSLs having
one or more sialic acid residues, are involved in regulation of
numerous cell biological events, including development, traf-
ficking, signaling, and cellular interactions. Gangliosides have
pathophysiological functions in diseases such as cancer, neuro-
degenerative disorders, and diabetes (1, 2). Sialic acid plays a
key role in the biological activities of gangliosides (3). For exam-
ple, we demonstrated that localization of insulin receptor in
caveolae is disrupted by elevated levels of endogenous GM3
during the state of insulin resistance. This effect is due to elec-
trostatic interaction between the lysine residue of insulin recep-
tor (Lys-944) and the carboxyl group of sialic acid of GM3
(4–8).
The structural diversity of GSLs arises from both the cer-
amide (Cer)moiety and glycan portion (Fig. 1). Cer is composed
of sphingosine and a single acyl chain (Fig. 1B). Cer acyl chains
vary in length of carbon backbone, degree of saturation, and the
presence/absence of -hydroxylation (9, 10).
Additional structural diversity of gangliosides arises from
sialic acid (acidic sugar molecule with characteristic nine-
carbon backbone) in the glycan portion. The most common
sialic acid in mammals is N-acetylneuraminic acid (Neu5Ac).
The other common sialic acid, N-glycolylneuraminic acid
(Neu5Gc), differs from Neu5Ac by the presence of an addi-
tional oxygen atom in the acyl group at position C5 (Fig. 1B).
Further structural diversity of sialic acids results from combi-
nations of this variation at position C5 with modifications of
hydroxyl groups at positions C4, C7, C8, and C9 by acetate,
lactate, sulfate, phosphate esters, or methyl ethers. Sialic acid
modifications greatly alter the size, hydrophobicity, net charge,
and enzymatic susceptibility of the parent compound (11).
Such structural divergence generated by different combina-
tions of Cer and sialic acids in gangliosides (Fig. 1B) results in a
huge numbers of “molecular species.” The identity of sialic acid
species in GM3 affects its biological properties. GM3 inhibits
EGFR-tyrosine kinase to differing degrees depending on its
sialic acid species. Such a difference apparently results from
differential carbohydrate-carbohydrate interactions between
EGFR and GM3 (Neu5Ac) or GM3 (Neu5Gc) (12). We have
also demonstrated relationships between various metabolic
diseases and levels of serum ganglioside GM3 “acyl chain”
molecular species. In particular, levels of GM3 with hydroxy-
lated acyl chain species in human serum show strong correla-
tions with several risk factors for metabolic diseases (13).
Taken together, the above findings indicate that differing
molecular species of a given ganglioside have distinct biological
properties and regulate specific and distinct biological events.
Elucidation of the function of each molecular species is impor-
tant and will provide new insights into ganglioside biology.
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Regulation of skeletal muscle formation is an essential pro-
cess in both normal development and repair of damagedmuscle
tissue. Differentiation of skeletal muscle cells (myocytes) is a
multistep process; the steps include signal transduction, cell
adhesion, and cell-cell fusion (14, 15). Gangliosides are known
to modulate various plasma membrane functions, e.g. cell-cell
interactions, signal transduction, and membrane ion channel
activity, through formation of functional membrane microdo-
mains termed “rafts.” Gangliosides are presumably involved in
these processes in myocytes (16–19); however, direct evidence
for such involvement is limited and fragmentary. In the present
studywe evaluated expression of gangliosides inmyoblasts dur-
ing differentiation.Weobserved striking changes in ganglioside
molecular species composition during differentiation and
assessed their differential functions. GM3 (Neu5Gc) and 16:0
acyl chain species, in particular, appear to play essential roles in
differentiation of myoblasts to myotubes.
Results
Changes in ganglioside quantity and quality duringmyogenic
differentiation
C2C12 is a myoblast line established from normal adult C3H
mouse leg skeletal muscle and is a well established model of in
vitro differentiation. C2C12 cells were cultured to 90% con-
fluence in growth medium and then cultured in differentiation
medium (DM; see “Experimental procedures”). Upon differen-
tiation stimulus, the cells gradually fused to form multinucle-
ated fibers (myotubes) (Fig. 2A) as expected. Differentiation to
myotubes was confirmed byWestern blotting. Levels of differ-
entiation marker proteins myogenin and myosin heavy chain
(MyHC) increased during differentiation (Fig. 2B). HPTLC
revealed the appearance of bands corresponding toGM3,GM2,
GM1, and GD1a mobilities during differentiation (Fig. 2C).
Amounts of all acidic GSLs increased gradually during differ-
entiation (Fig. 2C). In particular, GM3 content increased strik-
Figure 1. Structural diversity of gangliosides. A, ganglioside biosynthetic pathways. B, structures of ganglioside GM3 and sialic acid molecular species.
GM3molecular species andmyoblast differentiation
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ingly, with three major bands. Through day 2, the top band
(black pointer) and middle band (gray pointer) were the major
GM3 bands. From day 3 onward, the top band decreased, and
the middle band and bottom band (white pointer) became the
major bands. These findings revealed clear changes in quantity
and quality of GM3 molecular species, reflecting their impor-
tance in myogenic differentiation.
Changes of sialic acid species in gangliosides duringmyogenic
differentiation
GM3 synthase expression increased during differentiation
(Fig. 3A), consistent with the observed increase of GM3 levels
(Fig. 2A). To evaluate ganglioside changes during differentia-
tion, we used TLC immunostaining and fluorometric HPLC to
assess the quantity and quality of lipid-linked sialic acids.
Changes of sialic acid species of GM3 were confirmed by TLC
immunostaining using specific anti-GM3mAbs. For anti-GM3
(Neu5Ac) mAb GMR6, positive staining was detected at day 0,
and its intensity increased until day 3 and decreased thereafter
(Fig. 3B). In contrast, for anti-GM3 (Neu5Gc)mAbGMR8 (20),
positive bands were very weak until day 2 then increased grad-
ually after day 3 (Fig. 3B). High GM3 (Neu5Gc) expression was
maintained even on day 8.
Quantity and quality of lipid-linked sialic acids were next
assessed by fluorometric HPLC. In C2C12 myoblasts before
differentiation, almost all gangliosides contained Neu5Ac as
sialic acid in the glycan portion (Fig. 4A, f). After differentia-
tion induction, the total amount of lipid-linked sialic acid
increased (Fig. 4A, Œ), consistent with TLC immunostaining
results (Fig. 2C). The amount of lipid-linked Neu5Ac increased
gradually through day 3 and declined thereafter. In contrast,
lipid-linked Neu5Gc was barely detectable until day 2, in-
creased markedly on day 3, and by day 5 was the major sialic
acid species (Fig. 4A,Œ), again consistent with TLC results (Fig.
3, B and C). Taken together, these findings demonstrate that
sialic acid species of gangliosides change from Neu5Ac to
Neu5Gc during myogenic differentiation of C2C12 cells.
Figure 2. Changesof ganglioside expressionduringmyoblast C2C12dif-
ferentiation.DifferentiationofC2C12cellswas inducedbyculture inDM(see
“Experimental procedures”). A, morphology of proliferating cells (day 0) and
myotube formation on days 2–8, as revealed by phase-contrast microscopy.
Scale bar, 200m. B, expression of differentiationmarker proteins myogenin
and MyHC on various days, revealed by Western blotting. -actin: loading
control. Shown are representative Western blot images. C, GSL fraction was
prepared as described under “Experimental procedures.” Acidic GSLs
extracted from cells (0.2 mg protein basis) were spotted and separated on
HPTLC. GSLs were visualized by orcinol/sulfuric acid staining. Pointers indi-
cate GM3 species with differing polarity (see “Changes in ganglioside quan-
tity and quality duringmyogenic differentiation” under “Results”). Shown is a
representative HPTLC image.
Figure 3. Alteration of sialic acid species of GM3 during C2C12 differen-
tiation. A, the GM3 synthase mRNA expression levels on the indicated days,
determined by quantitative RT-PCR. Data represent the relative gene expres-
sion in cells of each day compared with that in cells of day 0 (set to 1.0 sepa-
rately for each target gene). Average -fold change was obtained from three
experiments, shown as the means  S.D. B, GM3 (Neu5Ac) expression,
detected by TLC immunostaining with specific mAb GMR6. C, GM3 (Neu5Gc)
expression, detectedby TLC immunostainingwith specificmAbGMR8. Point-
ers indicate the position of the GM3 band on HPTLC in Fig. 2.
GM3molecular species andmyoblast differentiation
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Neu5Gc residues on glycans are synthesized from CMP-
Neu5Gc through catalytic activity of sialyltransferases. There
are two CMP-Neu5Gc synthesis pathways in mammalian cells.
(i) In the salvage pathway, cells take up extracellular Neu5Gc-
containing glycoconjugates derived from foods such as meat,
fish, and eggs (or from serum in the case of cultured cell lines).
Subsequently, Neu5Gc-containing glycoconjugates are hydro-
lyzed to Neu5Gc monosaccharides in lysosomes. Neu5Gc
monosaccharides are transported to cytosol, and Neu5Gc is
activated toCMP-Neu5Gc byCMP-sialic acid synthetase in the
nucleus (21–23). (ii) In the de novo synthesis pathway, sialic
acid Neu5Ac is synthesized in cytosol and activated to CMP-
Neu5Ac in the nucleus, andCMP-Neu5Ac is subsequently con-
verted to CMP-Neu5Gc by the enzyme CMP-Neu5Ac hydrox-
ylase (CMAH) in cytosol (24, 25). CMP-Neu5Gc is transported
into theGolgi apparatus, where it undergoes transfer to glycans
through catalytic activity of various sialyltransferases. Reverse-
transcription polymerase chain reaction (RT-PCR) analysis of
the CMAH encoding gene (Cmah) revealed that expression
level of Cmah mRNA was very low during days 0–2 but
increased thereafter (Fig. 4C). Expression of CmahmRNA was
correlated with GM3 (Neu5Gc) level during C2C12 differenti-
ation (Figs. 3 and 4).
It is known that fetal bovine and horse serum contain
Neu5Gc glycoconjugates. Therefore, we analyzed sialic acid in
growth (10% FBS) and differentiation (2% HS) medium and
confirmed the existence of Neu5Gc in both mediums. Lipid-
linked Sia in the media is shown in Fig. 4B. Growth medium
contained large amounts of sialyl glycosphingolipids compare
with differentiation medium. Both mediums contained large
amounts of Neu5Ac compare with Neu5Gc. AlthoughNeu5Gc
glycosphingolipids, especially Neu5Gc-GM3 in medium, may
be taken up and utilized by differentiating cells, the amounts
would be small. Because the expression levels of both GM3
synthase and Cmah increased after the induction of differenti-
ation (Figs. 3A and 4C), we could conclude that the increase of
Neu5Gc-GM3 during differentiation may be due to the in-
creased de novo synthesis.
Changes of acyl chain structures in the Cer portion of GM3
duringmyogenic differentiation
Structural diversity of GM3 derived from acyl chain struc-
tures in C2C12 cells was evaluated by LC-MS/MS after differ-
entiation induction. On day 0 (Fig. 5A, black bars), the three
most abundant GM3 species detected were Neu5Ac-GM3
(d18:1–24:0), Neu5Ac-GM3 (d18:1–24:1), and Neu5Ac-GM3
(d18:1–16:0). Species with acyl chain carbon number 24
accounted for50% of total GM3 (Fig. 5B, green and blue col-
ors). Species that were abundant on day 0 contained primarily
Neu5Ac as sialic acid, consistent with TLC immunostaining
and HPLC results (Figs. 3 and 4).
On day 7, when differentiation was completed, Neu5Gc-
GM3 (d18:1–16:0) was themost abundantGM3molecular spe-
cies, and Neu5Ac-GM3 (d18:1–16:0) was the second most
abundant (Fig. 5A). GM3 species with 16:0 acyl chains
accounted for 70% of the total. Proportions of Neu5Ac spe-
cies were lower, and those of Neu5Gc species were higher on
day 7, but total amounts of 24:0 and 24:1 species showed little
Figure 4. Quantitative and qualitative analysis of lipid-linked sialic acid
species during C2C12 differentiation. A, lipid-linked sialic acid species in
C2C12 were quantified and qualified by fluorometric HPLC. Œ, total lipid-
linked sialic acids. f, lipid-linked Neu5Ac. , lipid-linked Neu5Gc. Detected
sialic acids: sum of sialic acids in GM3, GM2, GM1, and GD1a. B, lipid-linked
sialic acid species in growth and differentiation medium were quantified by
fluorometric HPLC. Shown is growthmedium containing 10% FBS (black bar)
and differentiationmedium containing 2%HS (gray bar). C, expression levels
of CmahmRNA, determined by agarose gel electrophoresis and quantitative
RT-PCR. Data represent the relative gene expression in cells of each day com-
pared with that in cells of day 0 (set to 1.0 separately for each target gene).
Average -fold change obtained from three experiments is shown as the
means S.D.
GM3molecular species andmyoblast differentiation
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change (Fig. 5A). The proportion of 16:0 species increased
markedly during differentiation (Fig. 5, A and B).
Expression of Cer synthases
Ceramide synthase (CerS) enzymes regulate synthesis of the
various Cer species. Six types of mammalian CerS have been
reported. Each CerS has a preference for a unique range of
acyl-CoA groups and, therefore, controls a particular subset of
Cer species. We used real-time PCR to determine expression
levels ofCerS1 throughCerS6 inC2C12 cells. The predominant
forms detected in these cells were CerS1, -2, -5, and -6. CerS2,
which catalyzes synthesis of ceramidewith very long acyl chains
such as C24, was most abundant in C2C12. CerS2 was slightly
increased after the induction of differentiation, but it was
decreased sharply during the differentiation process. On the
other hand the levels of CerS5 and -6, which catalyze C16-Cer
synthesis, remained constant (Fig. 6A). Therefore, the increase
ofGM3C16 species after differentiation (Fig. 5) could be attrib-
uted to the marked decrease of CerS2 expression during the
differentiation process (Fig. 6A).
We also examined changes in mRNA expression levels of
fatty acyl-CoA elongases (Elovls) during differentiation. Levels
Figure 5. LC-MS/MS analysis of GM3 molecular species during C2C12 differentiation. A, levels of GM3 molecular species in C2C12 cells. The eight most
abundant species on day 0 (black bars) and day 7 (gray bars) are shown. The amount of each species was quantified by LC-MS/MS using Neu5Ac GM3
(d18:1-[13C]16:0) as the internal standard, as described under “Experimental procedures.” y axis, amount of GM3 species (ng) present per 50g of cell protein.
B, proportions of GM3molecular species on days 0 and 7. Amounts of individual species were determined, and their proportions were calculated.
GM3molecular species andmyoblast differentiation
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of all five Elovls examined were lower on day 8 than on day 0
(Fig. 6B). This trend may also explain in part the increase of
shorter acyl-chain Cer species.
Effects of exogenous sialic acid and GM3 species on cell
morphology
Sialic acid and acyl chain structures of GM3 showed notable
changes duringC2C12 cell differentiation. The potential role of
such changes was investigated by adding various sialic acid and
GM3 molecular species to culture medium.
Sialic acid monosaccharide (Neu5Ac or Neu5Gc) was added
during medium change each day to change the sialic acid spe-
cies of sialylglycoconjugates. Treatment with 2 mM Neu5Ac or
Neu5Gc efficiently increased intracellular Sia monosaccharide
(Fig. 7A, left panel), so exogenous sialic acids were taken up by
C2C12 cells. After 2 days the amount of lipid-linked Neu5Gc
exceeded that of Neu5Ac in cells treated with 2 mM Neu5Gc,
although Neu5Ac was the major sialic acid in normal and
Neu5Ac-treated cells (Fig. 7A, right panel). Thus, we were able
to change the ratio of sialic acid species in gangliosides by treat-
mentwithNeu5Gc.Cellmorphology onday 6 is shown in Fig. 7,
B and C.
Sialic acid species differentially affectedmorphology of myo-
blasts and/or myofibers. The ratio of long fibers was increased
by treatment with Neu5Gc (Fig. 7C, right panel). And the
formed fiber width was small (Fig. 7C, left panel). Therefore,
cells treatedwithNeu5Gcmonosaccharide formed longer, nar-
rower myofibers. Neu5Ac or Neu5Gc treatment had no effect
on the expression of differentiation marker proteins myogenin
and MyHC (Fig. 7D, left panel). However, phosphorylation of
paxillin, which regulates adhesion state, was increased by treat-
ment with Neu5Gc (Fig. 7D, right panel). These findings sug-
gest that sialic acid affects cell morphology via control of cyto-
skeleton formation or myofiber adhesion state.
Although Neu5Ac was taken up by cells during Neu5Ac
treatment, the quality and quantity of glycosphingolipids was
not drastically changed (Fig. 7A). The ratio of shorter length
myotubes was slightly increased by Neu5Ac treatment. These
changes may not be an effect of only change in GLSs, although
these results suggest that extracellular sialic acid affected myo-
blast differentiation.
Exogenous gangliosides can be inserted into the outer leaflet
of plasma membranes and be partially taken up and metabo-
lized (26). We confirmed the uptake and increase of GM3 in
cells by TLC and fluorometric HPLC (Fig. 8A). 25 M exoge-
nous GM3 efficiently increased cellular gangliosides (Fig. 8A,
left panel) and lipid linked sialic acids (Fig. 8A, right panel).
Therefore, we addedGM3 species, shorter (16:0) species, which
are the major species after differentiation, and longer (24:0 or
18:0) species, which are themajor species before differentiation
to evaluate their properties. In experiments with different GM3
molecular species, d18:1–16:0 species were well aligned and
formed numerous myotubes, whereas cells treated with GM3
d18:1–18:0 or d18:1–24:0 species were poorly aligned and
formed fewer myotubes (Fig. 8B); the ratio of cells with shorter
length and larger width was increased when treated with GM3
d18:1–18:0 or d18:1–24:0 species (Fig. 8C). Although expres-
sion level of myogenin was relatively unaffected by treatment
with different GM3 molecular species, the level of MyHC was
notably reduced by treatment with GM3 d18:1–18:0 or d18:1–
24:0 species (Fig. 8D). Cells treated with GM3 d18:1–16:0
formed relatively longer myofibers.
These findings indicate that increased longer acyl-chain
GM3 species inhibit some signaling in differentiation pro-
cesses such as fusion process and/or formation of myotubes,
whereas shorter acyl-chain GM3 species do not inhibit, or
might, enhance.
In this study we found an association of GM3 lipid species
change and differentiation in myoblast. The results shown in
Fig. 7 and in Fig. 8 are consistent with the hypothesis that myo-
blasts may regulate their differentiation by changing GSLs
species.
Discussion
Skeletal muscle differentiation comprises a chain of complex
processes in which cell plasma membranes play a crucial role.
Cell-to-cell adhesion and recognition are essential for the dif-
ferentiation process. It is necessary for progenitor cells to con-
tact numerous similar cells and respond to inductive signals in
order to undergo a coordinated process of differentiation. In
Figure 6. Changes in expression of Cer synthase mRNAs during C2C12
differentiation. A, expression levels of CerS mRNAs, determined by quanti-
tative RT-PCR. -Fold change was calculated as 2CT with tubulin used as
the endogenous control. B, expression levels of Elovl mRNAs during differen-
tiation, determined by quantitative RT-PCR. Data represent the relative gene
expression in cells of each day compared with that in cells of day 0 (set to 1.0
separately for each target gene). Average -fold change obtained from three
experiments is shown the means S.D.
GM3molecular species andmyoblast differentiation
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the final steps of differentiation, plasma membranes fuse with
each other (14, 15, 27). Biochemical characteristics of plasma
membranes thus have important effects on skeletal muscle dif-
ferentiation. GSLs, particularly gangliosides, help determine
plasma membrane properties and play essential roles in regu-
lating many biological processes, including cell-cell interac-
tions and signal transduction (1, 2). Expression of GM3, GM2,
GM1, and GD1a has been reported in myoblast cell line C2C12
(16–18); however, changes in ganglioside expression and func-
tions of specific ganglioside species during myogenic differen-
tiation have not been studied. We analyzed changes in gangli-
oside species during myogenic differentiation using C2C12
cells as a model. We demonstrated for the first time striking
changes in quantity and quality of gangliosides during the dif-
ferentiation process. Alterations of molecular species of GM3,
themajor ganglioside in C2C12 cells, were particularly notable.
Sialic acid species in GM3 were changed from Neu5Ac to
Neu5Gc through elevated expression of hydroxylase CMAH.
GM3 species with 16:0 acyl chains were greatly increased. To
elucidate the function of this GM3 molecular species change,
we added sialic acid monosaccharide or synthetic GM3 acyl
chain species to culture medium. Our findings (Figs. 6 and 7)
Figure 7. Effects of sialic acid monosaccharide supplementation on C2C12 differentiation. A, uptake and utilization of exogenous sialic acids in C2C12
cells. 2mMNeu5AcorNeu5Gcwas added to thedifferentiationmedium.After 2 days Siamonosaccharide in cytosol (left panel) and lipid-boundSia (right panel)
were measured as described under “Experimental procedures.” B, phase-contrast microphotographs on day 6 of cells treated with sialic acid (2 mM) in DM. C,
effects of exogenous sialic acids onmorphology ofmyofibers. The ratio of each fiber length (right panel) andwidth (left panel) are shown (control andNeu5Gc;
n 100, Neu5Ac; n 89). D, expression levels, on day 6 of differentiation, of marker proteins myogenin andMyHC in cells treated with sialic acid in DM (right
panel). Shown are the effects of sialic acids on the phosphorylation state of paxillin on days 1and 2 (left panel). Shown are representativeWestern blot images.
GM3molecular species andmyoblast differentiation
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indicate that sialic acid species affect cell morphology and
that GM3 acyl chain structures play key roles in regulating
differentiation.
In regard to GM3 function in myogenic differentiation, pre-
vious studies indicate that sialidase (Neu3), which is localized in
the plasma membrane and hydrolyzes GM3 and other gan-
gliosides, affects differentiation of C2C12 cells. Neu3 overex-
pression delayed myoblast differentiation and induced hy-
pertrophic myotube formation, whereas differentiation was
inhibited by Neu3 gene silencing (16–18). The Neu3 protein
per se presumably modulates certain cell functions, but these
studies suggest that GM3 in appropriate amounts also plays an
important role in normal C2C12 differentiation, most likely via
modulation of EGFR signaling.We used a GSL synthesis inhib-
itor to confirm thatGSLs in appropriate amounts are important
inmyofiber formation (data not shown). Thus, proper amounts
of GM3 are required at each step in the process for normal
myogenic differentiation. We observed here for the first time
Figure 8. Effects of GM3 acyl chain structure on C2C12 differentiation. A, uptake of exogenous GM3. Shown is TLC analysis (right panel), and the amounts
of lipid-linked sialic acids (left panel) of C2C12 cells treated with 25 mM GM3 for 24 h. B, phase-contrast microphotographs on day 6 of cells treated with three
GM3species (25M).C, effects of exogenous sialic acidsonmorphologyofmyofibers. The ratioof each fiber length (right panel) andwidth (left panel) are shown
(n20).D, expression levels onday 6of differentiationmarker proteinsmyogenin andMyHC in cells treatedwith threeGM3 species. Shownare representative
Western blot images.
GM3molecular species andmyoblast differentiation
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striking changes in GM3 quality during differentiation; i.e.
major alterations in sialic acid species and acyl chain struc-
tures (Figs. 2–4). Our findings suggest that ganglioside qual-
ity as well as quantity is important at each step for normal
myogenic differentiation.
Sialic acid species and the acyl chain structures of ganglio-
sides are involved inmaintaining cellmembrane properties and
lipid microdomain structures. Hashimoto and co-workers (28,
29) observed that disruption of lipid rafts by cholesterol deple-
tion directly blocked the plasma membrane fusion that nor-
mally occurs as part of myogenic cell fusion. The molecular
mechanisms that control cell fusion and other steps of myo-
genic differentiation remain to be elucidated; however, plasma
membrane rafts clearly play an important role. A number of
membrane molecules have been implicated in regulation of
myogenic differentiation. Extracellular matrix receptor integ-
rins (30) and adhesion molecules such as cadherins, NCAM,
and CD9 (31–33) are involved in regulation of the recognition
and adhesion steps in myoblast differentiation and mainte-
nance of myofibers. Crucial molecules (e.g. BAI1, myomaker)
involved in regulation of initiation signals for myogenic differ-
entiation and plasma membrane fusion were discovered in
2013 (34, 35). Such transmembrane proteins are localized in
specific regions of the plasma membrane during differentia-
tion; it is thus possible that various GM3 molecular species
interact specifically with the proteins, directly or indirectly, to
regulate their functions and localization. Membrane fluidity
affects myogenic differentiation, particularly the plasma mem-
brane fusion process (36–38); thus, another possibility is that
concentrations of various GSL molecular species in myoblasts
help regulate membrane fluidity and are strictly controlled for
this purpose.
Our knowledge of molecular mechanisms that regulate dis-
tribution and expression of GSL molecular species and other
plasma membrane molecules remains fragmentary. The CerS
enzymes provide one regulatory mechanism for expression of
GSL acyl chain molecular species. Six mammalian CerSs have
been described, each utilizing fatty acyl CoAs with differing
chain lengths for N-acylation of the sphingoid long chain base.
CerS5 and CerS6 catalyze synthesis of C16 acyl chain Cer spe-
cies (9, 10). Most studies to date focused on roles of CerSs in
regulation of sphingolipids have relied on CerS overexpression
to increase Cer synthesis. Therefore, it remains unclear how
individual CerSs contribute to a steady-state sphingolipid pool
inmammalian cells, andwhethermaintenance of sphingolipids
with specific acyl chains depends on specific CerSs (39). C16
GSL species were strikingly increased during C2C12 differenti-
ation in the present study (Fig. 5). The increase of GM3 C16
species after differentiation could be attributed to the marked
decrease of CerS2 expression during the process of differentia-
tion (Fig. 6A). We also observed that expression levels of Elovls
declined during myogenic differentiation, which may help
account for increased levels of shorter acyl-chain species (Fig.
6B). Future studies may reveal unknownmechanisms for regu-
lation of GSL molecular species by inter-regulation of CerSs
and Elovls.
By treatment with exogenous GM3 species, cellular ganglio-
sides were changed (Fig. 8). We found that increased longer
acyl-chain GM3 species inhibited differentiation, whereas
shorter acyl-chain GM3 did not result in inhibition (Fig. 8, B
and C). These results suggest that myoblasts regulate some sig-
naling processes during differentiation, such as fusion pro-
cesses and/or formation of myotubes, by changing the metab-
olism of ganglioside acyl chain species.
Besides changes in acyl chains of GM3molecular species, the
present study demonstrates for the first time changes of sialic
acid species from Neu5Ac to Neu5Gc during differentiation.
We also observed morphological changes in myotubes after
treatment with Neu5Gc (Fig. 7, B and C). This phenomenon
suggests a function for Neu5Gc glycoconjugates in the process
of myogenic differentiation, especially in the regulation of cell
morphology. Although during the exogenous treatment we
employed, the ratio of Neu5Gc was increased in both glycopro-
teins and glycolipids (data not shown); therefore, we cannot
concluded the effects observedwere the result of Neu5GcGM3
alone. Several groups have described changes of sialic acid spe-
cies on glycans during various biological processes (40–43). It
appears that Neu5Gc expression can also be affected by cell
activation and disease status. Cmah mRNA expression is
altered during lymphocyte activation in mice (41, 42), and
Neu5Gc treatment modifies interactions between glycans and
their binding proteins. Taken together, these past and present
findings indicate that the change of sialic acid species from
Neu5Ac to Neu5Gc is crucial for myogenic differentiation in
mice. Deletion of Cmah in mice increased the severity of mus-
cular dystrophy (44, 45), suggesting that this gene is a genetic
modifier of muscle homeostasis. Taken together, our results
suggest that myoblasts regulate their differentiation by chang-
ing themetabolism of sialic acids, ceramide, and, consequently,
gangliosides.
Wewant to elucidate the function of specific GM3molecular
species, which have their expression levels affected before and
after myogenic differentiation, especially focusing on NeuGc
GM3 with a C16 acyl chain as shown in Fig. 5A. We confirmed
the change in expression of some genes related to the synthesis
of this molecule. Therefore, we tried to modify the expression
of these genes (such as GM3 synthase, Cmah, and CerSs) to
show their function in myogenic differentiation. However, we
could not establish gene-modified C2C12 cells while maintain-
ing differentiation potency. Therefore, wewill report further on
these investigations in our next manuscript.
In conclusion, the present results demonstrate that quantity
and quality of GM3 change greatly during myoblast C2C12 dif-
ferentiation and suggest that these changes play a key role in
regulation of the differentiation process. These findings help
clarify the significance of GSL structural diversity in mamma-
lian cells. Our ongoing studies, using genetically modified mice
and cells, are focused on roles of GM3 molecular species in
function and regeneration of muscle cells and tissues.
Experimental procedures
Materials
Hybridoma cells producing anti-GM3 (Neu5Gc) monoclonal
antibody (mAb) GMR8 were kindly donated by Ikuo Kawashima
(20), RIKEN BioResource Center. Anti-GM3 (Neu5Ac) mAb
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GMR6 was from Seikagaku Co. (Tokyo, Japan). Anti-myogenin
andmyosin heavy chain antibodieswere frome-Bioscience (Santa
Clara, CA).GM3molecular specieswere synthesized according to
previous reports (46, 47). Neu5Ac GM3 (d18:1-[13C]16:0), an
internal standard for quantification by LC-MS/MS, was from
Tokyo Chemical Industry (Tokyo, Japan).
Cell culture
C2C12 myoblast cells were obtained from RIKEN Bio-
Resource Center (Tsukuba, Japan) and cultured in Dulbecco’s
modified Eagle’s medium (DMEM; Nacalai; Kyoto, Japan) con-
taining 10% heat-inactivated fetal bovine serum at 37 °C in 5%
CO2 atmosphere. To induce differentiation, growth medium
was replaced with DMEM containing 2% horse serum (DM)
when cells reached 90% confluency. Cells were replenished
with fresh DM every 24 h. To evaluate the effects of exogenous
sialic acids, Neu5Ac or Neu5Gc (2 mM) were added to DM. To
evaluate the effects of exogenous GM3, synthetic GM3 acyl
chain species (25 M) were added to DM.
Analysis of GSLs
Analysis of GSLs by TLC was performed as described origi-
nally in Refs. 48 and 49 and slightly modified (50). In brief, total
cell lipids were extracted using chloroform/methanol, and
extracts were applied to DEAE-Sephadex A-25 column equili-
brated with chloroform/methanol/water (30:60:8, v/v/v). The
columnwaswashedwith the same solvent, and acidicGSL frac-
tion was eluted with chloroform/methanol/1 M sodium acetate
(30:60:8, v/v/v). Acidic and neutral lipidswere subjected tomild
alkaline hydrolysis and desalted using a Sep-Pak C18 cartridge.
Acidic GSLs were spotted on a TLC plate and developed with
chloroform/methanol/0.2% CaCl2 (60:25:4, v/v/v). GSLs were
visualized by orcinol/sulfuric acid staining.
TLC immunostaining
AcidicGSLswere spotted on aTLCplate and developedwith
chloroform/methanol/0.2% CaCl2 (60:25:4, v/v/v). The dried
plate was dipped in cyclohexane containing 0.1% (w/v) poly-
(isobutyl methacrylate) for 1min, blocked by incubation in PBS
containing 1%BSA at room temperature for 1 h, incubatedwith
anti-GM3 mAb GMR6 (GM3(Neu5Ac) specific) or GMR8
(GM3(Neu5Gc) specific) in PBS containing 1% BSA at room
temperature for 2 h, washed 5 times with PBS, and incubated
with anti-mouse IgM horseradish peroxidase (HRP)-conju-
gated antibody at 37 °C for 1 h. HRP was detected by the addi-
tion of appropriate substrates following the manufacturer’s
instructions.
Sialic acid analysis by fluorometric HPLC
Sialic acids were hydrolyzed from acidic GSL fractions by
trifluoroacetic acid. An aliquot of the supernatant was lyophi-
lized and then incubated with 1,2-diamino-4,5-methylene
dioxybenzene as described previously (51). 1,2-Diamino-4,5-
methylene dioxybenzene-labeled sialic acids were separated
and detected using an HPLC system (JASCO; Tokyo, Japan)
equipped with a reversed-phase C18 column (Wakopak
Handy-ODS (4.6mm 250mm);WakoPureChemical,Osaka,
Japan).
RT-PCR
Total RNAs were prepared from cells using TRIzol reagent.
Reverse transcription of total RNA was performed to generate
first-strand cDNA. For detection of cDNA of mouse CMP-
sialic acid hydroxylase, we performed RT-PCR assays using a
primer set based on sequences of CMP-sialic acid hydroxylase
(5	-ctgatcccaggtctcctgaa-3	, 5	-agcctctccaaccagtcaga-3	) and
GAPDH (5	-acaaaatggtgaaggtcggt-3	, 5	-tccagggtttcttactcctt-
3	). For quantitative real-time PCR, cDNA was prepared from
total RNA using a PrimeScript™ RT Reagent kit (Takara Bio).
RT-PCRwas performed and analyzed using SsoFast™ EvaGreen
Supermix on a Real-Time PCR system (Bio-Rad). Expression
values were normalized to tubulin, and relative mRNA expres-
sion was calculated as described by Livak and Schmittgen (52).
Primers used are listed in Table 1.
Mass spectrometric analysis
Neu5Ac GM3 (d18:1-[13C]16:0) was added to acidic GSL
samples as the internal standard. GM3 molecular species were
quantified using HPLC coupled with electrospray ionization
tandem mass spectrometry (MS/MS) in multiple reaction-
monitoring negative ionizationmode. The triple-stage quadru-
pole (TSQ) Vantage AM instrument (Thermo Fisher, Wal-
tham, MA) was calibrated by directly infusing a mixture of
GM3 species extracted from milk, and all ion source parame-
ters and ionization conditions were optimized to improve sen-
sitivity. GSLs were dissolved in methanol, injected onto an
HPLC pump (Accela 1250, Thermo Fisher), and separated
using a Develosil carbon 30 column (C30-UG-3–1  50 mm,
Nomura Co.; Aichi, Japan). The gradient program started with
100% solvent A (20%H2O, 50% 2-propanol, 30%methanol con-
Table 1
Primers used to specifically enhance eachmRNA fragment
Gene Primer sequence
CerS1 Forward 5	-TGACTGGTCAGATGCGTGA-3	
Reverse 5	-TCAGTGGCTTCTCGGCTTT-3	
CerS2 Forward 5	-TCATCATCACTCGGCTGGT-3	
Reverse 5	-AGCCAA AGAAGGCAGGGTA-3	
CerS3 Forward 5	-ATCTCGAGCCCTTCTTCTCC-3	
Reverse 5	-CTGGACGTTCTGCGTGAAT-3	
CerS4 Forward 5	-TGCGCATGCTCTACAGTTTC-3	
Reverse 5	-CTCGAGCCATCCCATTCTT-3	
CerS5 Forward 5	-TCCATGCCATCTGGTCCTA-3	
Reverse 5	-TGCTGCCAGAGAGGTTGTT-3	
CerS6 Forward 5	-GGGTTGAACTGCTTCTGGTC-3	
Reverse 5	-TTTCTTCCCTGGAGGCTCT-3	
Cmah Forward 5	-GAAAGGCCTGTGTTTTGGAA-3	
Reverse 5	-TCATGAACCGCAGACTTTTG-3	
St3gal5 Forward 5	-GTGGACCCTGACCGGATAAAG-3	
(GM3 S) Reverse 5	-AACAGAGCCATAGCCGTCTTC-3	
Tubulin Forward 5	-CACTACACCATTGGCAAGGA-3	
Reverse 5	-TGTGGAAAACCAAGAAGCCC-3	
Elovl 1 Forward 5	-GGTGGGGGATAAAAATTGCT-3	
Reverse 5	-CCAAGGGCAGACAATCCATA-3	
Elovl 2 Forward 5	-GACGCTGGTCATCCTGTTCT-3	
Reverse 5	-GCTTTGGGGAAACCATTCTT-3	
Elovl 3 Forward 5	-TTTGCCATCTACACGGATGA-3	
Reverse 5	-CGTGTCTCCCAGTTCAACAA-3	
Elovl 4 Forward 5	-TTTGGTGGAAGCGATACCTG-3	
Reverse 5	-ATGTCCGAGTGTAGAAGTTG-3	
Elovl 5 Forward 5	-CTCTCGGGTGGCTGTTCTT-3	
Reverse 5	-AGAGGCCCCTTTCTTGTTGT-3	
Elovl 6 Forward 5	-ACAATGGACCTGTCAGCAAA-3	
Reverse 5	-GTACCAGTGCAGGAAGATCAGT-3	
Elovl 7 Forward 5	-ATGGGACCAGCCTACCAGAA-3	
Reverse 5	-TTGCAGTCCTCCATGAAGAA-3	
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taining 0.1% acetic acid and 0.1% ammonia) for 5 min, then
ramped to 100% solvent B (2% H2O, 50% 2-propanol, 48%
methanol containing 0.1% acetic acid, and 0.1% ammonia) over
30 min. 100% solvent B was maintained for 4 min, then the
solvent was returned to 100% solvent A over 1 min and held
there for 10 min. Flow was 50 l/min throughout the chro-
matographic run. 2500 V potential was applied between ion
source and electrospray needle. The carrier gas was nitrogen.
Relative abundances of molecular species were assessed based
on relative percentage of internal standard. All GM3molecular
species may not necessarily have identical ionization efficien-
cies; however, because of limited availability of pure molecular
species standards, we assumed that all species have ionization
efficiencies comparable with that of the internal standard.
Thus, in evaluating relative abundances of molecular species,
detected amounts are compared that may not necessarily rep-
resent absolute amounts (13). The details for the assignment of
ganglioside molecular species are shown in Table 2.
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